| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |